In this video, Motley Fool health care analyst David Williamson takes us through some of the biggest investing stories in the health care space yesterday. He tells us about Ligand's (NASDAQ:LGND) big FDA win -- and why its relevance may be very short-lived -- and how AVEO Pharmaceuticals (NASDAQ:AVEO) is bouncing back after taking a big hit last week and what's ahead for the company. He also discusses how pharmaceutical giant Pfizer (NYSE:PFE) doesn't always get what it wants.
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
What You Need to Know: Ligand, AVEO, and Pfizer
NYSE: PFE
Pfizer

Monday's market movers in the biotech world.
David Williamson owns shares of Pfizer. Max Macaluso has no positions in the stocks mentioned above. The Motley Fool has no positions in the stocks mentioned above. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned



*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles





Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.